eylea solution for injection in prefilled syringe 2mg
bayer (south east asia) pte ltd - aflibercept - injection, solution - 2.0mg/50mcl - aflibercept 2.0mg/50mcl
eylea solution for injection in vial 2mg
bayer (south east asia) pte ltd - aflibercept - injection, solution - 2.0mg/50mcl - aflibercept 2.0mg/50mcl
eylea
bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - ophthalmologicals - eylea is indicated for adults for the treatment of:neovascular (wet) age-related macular degeneration (amd);visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo);visual impairment due to diabetic macular oedema (dme);visual impairment due to myopic choroidal neovascularisation (myopic cnv).
eylea solution
bayer inc - aflibercept - solution - 2mg - aflibercept 2mg - eent drugs, miscellaneous
eylea 40mg/ml solution for injection
bayer pharma ag - aflibercept - solution for injection - 40mg/ml
eylea
bayer israel ltd - aflibercept - solution for intravitreal injection - aflibercept 40 mg/ml - aflibercept - eylea is indicated for adults for the treatment of • neovascular (wet) age-related macular degeneration (amd)• visual impairment due to macular oedema secondary to retinal vein occlusion (branch crvo or central rvo)• visual impairment due to diabetic macular oedema (dme)• visual impairment due to myopic choroidal neovascularisation (myopic cnv).
eylea solution for injection
bayer ag - aflibercept - solution for injection - 40mg/ml
eylea solution
bayer inc - aflibercept - solution - 2mg - aflibercept 2mg - eent drugs, miscellaneous
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - ophthalmologicals - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5.1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5.1),visual impairment due to diabetic macular oedema (dme) (see section 5.1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.1).
eylea hd solution
bayer inc - aflibercept - solution - 8mg - aflibercept 8mg